Perioperative Antibiotic Therapy to Prevent Cardiac Implantable Electronic Device Infections.

PHASE3CompletedINTERVENTIONAL
Enrollment

1,010

Participants

Timeline

Start Date

April 1, 2016

Primary Completion Date

March 31, 2021

Study Completion Date

September 30, 2021

Conditions
Sick Sinus SyndromeComplete Heart BlockSyncopeChronic Systolic Heart Failure
Interventions
DRUG

polymixin/bacitracin

Antibacterial irrigation

DRUG

cephalexin, or levofloxacin, or clindamycin

Post operative oral antibiotics

DRUG

Saline

Saline irrigation

Trial Locations (1)

37232

Vanderbilt University Medical Center, Nashville

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Thomas Jefferson University

OTHER

collaborator

The Cooper Health System

OTHER

collaborator

Valley Health System

OTHER

collaborator

Medtronic

INDUSTRY

lead

Vanderbilt University Medical Center

OTHER